NBHC National Bank (NBHC) Insider Trading, Ownership & Congress Trades
Banks · National commercial banks · CIK 0001475841
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $2.1M priced
What the filings say about NBHC
Insiders, 180 days
-$40.3K net sold
1 seller · 0% of sales under a 10b5-1 plan
National Bank insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, National Bank Holdings Corp insiders sold a net $40.3K of stock across 38 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Nov 11, 2025.
- The trade is 2.6% of the 37,157 shares held after it.
- No other insider sold within 30 days.
Insider activity: Director Spring Maria F sold about $40.3K of NBHC on May 20, 2026.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 4.5% of the 536,504 shares held after it.
- No other insider bought within 30 days.
Insider activity: Exec Mng Dir of Strategic Init Steinmetz John bought about $1.0M of NBHC on Feb 11, 2026, the largest insider purchase at the company on our record.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on May 27, 2025.
- The trade is 17.4% of the 35,663 shares held after it.
- No other insider sold within 30 days.
Insider activity: Director Spring Maria F sold about $230.8K of NBHC on Nov 11, 2025.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 2.7% of the 42,573 shares held after it.
- No other insider sold within 30 days.
Insider activity: Director Spring Maria F sold about $43.2K of NBHC on May 27, 2025.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Nov 15, 2021.
- The trade is 13.4% of the 143,210 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: CHIEF RISK MNGMT OFFICER Newfield Richard U Jr. sold about $959.3K of NBHC on Nov 13, 2024; 1 other insider sold within 30 days.38 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$40.3K over 180 days
more than 63% of Banks
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+2.1% year over year
below 71% of Banks
Margin
232.4% net margin
more than 60% of Banks
Buybacks
$27.2M repurchased, FY to 2026-06-30
more than 68% of Banks
Short interest
4.6% of the float short (float per yahoo 2026-10-26) · 4.0 days to cover · settled 2026-09-30
more than 71% of Banks
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch NBHC
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+8.9%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns NBHC: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in NBHC
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
NBHC planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$3.7M
$2.7M
$1.2M
+33%
+53%
2024
$3.9M
$5.1M
$1.1M
+46%
+43%
2023
$3.6M
$3.3M
$1.0M
+22%
+27%
2022
$3.3M
$2.8M
$1.0M
+34%
+27%
2021
$3.0M
$5.6M
$957.7K
+37%
+37%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $40.3K sold by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
NBHC financials
Revenue growth
+2.1%
XBRL, annual
Net margin
232.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$48.5M
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM NBHC
| FY Dec 2025 | $47.1M |
| FY Dec 2024 | $46.2M |
| FY Dec 2023 | $46.9M |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | $11.9M |
| Mar 2026 | $11.4M |
| Dec 2025 | $13.9M |
| Sep 2025 | $11.3M |
| Jun 2025 | $11.1M |
| Mar 2025 | $10.8M |
| Dec 2024 | $11.4M |
| Sep 2024 | $12.1M |
At each fiscal year end
Single quarter
Net margin, TTM
+203.3%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM NBHC
| FY Dec 2025 | +232.4% |
| FY Dec 2024 | +257.1% |
| FY Dec 2023 | +302.7% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | +221.9% |
| Mar 2026 | +183.1% |
| Dec 2025 | +115.1% |
| Sep 2025 | +312.9% |
| Jun 2025 | +306.1% |
| Mar 2025 | +223.9% |
| Dec 2024 | +246.9% |
| Sep 2024 | +273.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM NBHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
0.12x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity NBHC
| FY Dec 2025 | 0.04x |
| FY Dec 2024 | 0.04x |
| FY Dec 2023 | 0.04x |
| FY Dec 2022 | 0.05x |
| FY Dec 2021 | 0.05x |
| Jun 2026 | 0.12x |
| Mar 2026 | 0.12x |
| Dec 2025 | 0.04x |
| Sep 2025 | 0.04x |
| Jun 2025 | 0.04x |
| Mar 2025 | 0.04x |
| Dec 2024 | 0.04x |
| Sep 2024 | 0.04x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.84x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt NBHC
| FY Dec 2025 | 2.98x |
| FY Dec 2024 | 2.85x |
| FY Dec 2023 | 3.08x |
| FY Dec 2022 | 3.98x |
| FY Dec 2021 | 4.55x |
| Jun 2026 | 0.84x |
| Mar 2026 | 0.33x |
| Dec 2025 | 2.98x |
| Sep 2025 | 3.12x |
| Jun 2025 | 3.04x |
| Mar 2025 | 3.02x |
| Dec 2024 | 2.85x |
| Sep 2024 | 2.82x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+6.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity NBHC
| FY Dec 2025 | +8.1% |
| FY Dec 2024 | +9.4% |
| FY Dec 2023 | +12.3% |
| FY Dec 2022 | +7.4% |
| FY Dec 2021 | +11.3% |
| Jun 2026 | +6.5% |
| Mar 2026 | +7.1% |
| Dec 2025 | +8.1% |
| Sep 2025 | +9.1% |
| Jun 2025 | +9.2% |
| Mar 2025 | +8.7% |
| Dec 2024 | +9.4% |
| Sep 2024 | +10.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets NBHC
| FY Dec 2025 | +1.1% |
| FY Dec 2024 | +1.2% |
| FY Dec 2023 | +1.5% |
| FY Dec 2022 | +0.8% |
| FY Dec 2021 | +1.3% |
| Jun 2026 | +0.9% |
| Mar 2026 | +0.9% |
| Dec 2025 | +1.1% |
| Sep 2025 | +1.2% |
| Jun 2025 | +1.2% |
| Mar 2025 | +1.1% |
| Dec 2024 | +1.2% |
| Sep 2024 | +1.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital NBHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed NBHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
16.41x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing NBHC
| FY Dec 2025 | 13.34x |
| FY Dec 2024 | 13.98x |
| FY Dec 2023 | 10.00x |
| FY Dec 2022 | 19.30x |
| FY Dec 2021 | 14.60x |
| Jun 2026 | 18.67x |
| Mar 2026 | 14.61x |
| Dec 2025 | 13.34x |
| Sep 2025 | 12.27x |
| Jun 2025 | 12.17x |
| Mar 2025 | 13.24x |
| Dec 2024 | 13.98x |
| Sep 2024 | 13.03x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.6B
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value NBHC
| FY Dec 2025 | $1.1B |
| FY Dec 2024 | $1.6B |
| FY Dec 2023 | $1.3B |
| FY Dec 2022 | $1.4B |
| FY Dec 2021 | $525.1M |
| Jun 2026 | $1.8B |
| Mar 2026 | $1.5B |
| Dec 2025 | $1.1B |
| Sep 2025 | $969.3M |
| Jun 2025 | $1.2B |
| Mar 2025 | $1.3B |
| Dec 2024 | $1.6B |
| Sep 2024 | $1.5B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield NBHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -23%, PEG needs growth
PEG, trailing NBHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 0.14x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 2.44x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $47.1M | $46.2M | $46.9M | $38.3M |
| Net income | $109.6M | $118.8M | $142.0M | $71.3M |
| EPS (diluted) | 2.85 | 3.08 | 3.72 | 2.18 |
| Operating cash flow | $162.4M | $155.3M | $166.9M | $214.6M |
| Cash | $417.1M | $127.8M | $190.8M | $195.5M |
| Long-term debt | $54.5M | $54.5M | $54.2M | $53.9M |
| Buybacks | $15.2M | n/a | n/a | n/a |
| Dividends paid | $46.1M | $42.9M | $39.6M | $30.4M |
SEC XBRL, fiscal years, as known on 2026-10-28
NBHC Stock Sonar score 5/7 axes
Find similar shapesCompareNBHC ranks highest on financial health (68th percentile) and risk and compliance (32nd), and lowest on profitability (26th), among Banks peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
NBHC filings, in plain words
Are National Bank insiders buying or selling NBHC?
In the 180 days to 2026-10-28, National Bank insiders were net sellers, a net $40.3K across purchases and sales reported on Form 4, by 1 seller.
Read the full summary
In the 180 days to 2026-10-28, National Bank insiders were net sellers of NBHC, a net $40.3K across purchases and sales reported on Form 4 by 1 seller. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
